INTRODUCTION: Neuroenhancing therapies are desired because repair of nerve injuries can fail to achieve recovery. We compared two neuroenhancing therapies, electrical stimulation (ES) and systemic tacrolimus (FK506), for their capabilities to enhance regeneration in the context of a rat model. METHODS: Rats were randomized to four groups: ES 0.5 mA, ES 2.0 mA, FK506, and repair alone. All groups underwent tibial nerve transection and repair, and outcomes were assessed by using twice per week walking track analysis, cold allodynia response, relative muscle mass, and nerve histology. RESULTS: Electrical stimulation and FK506 groups demonstrated improved functional recovery and myelinated axon counts distal to the repair compared with repair alone. Electrical stimulation provided improvements in nerve regeneration that were not different from optimized FK506 systemic administration. DISCUSSION: Providing ES after nerve repair improved regeneration and recovery in rats, with minimal differences in therapeutic efficacy to FK506, further demonstrating its clinical potential to improve management of nerve injuries.
INTRODUCTION: Neuroenhancing therapies are desired because repair of nerve injuries can fail to achieve recovery. We compared two neuroenhancing therapies, electrical stimulation (ES) and systemic tacrolimus (FK506), for their capabilities to enhance regeneration in the context of a rat model. METHODS:Rats were randomized to four groups: ES 0.5 mA, ES 2.0 mA, FK506, and repair alone. All groups underwent tibial nerve transection and repair, and outcomes were assessed by using twice per week walking track analysis, cold allodynia response, relative muscle mass, and nerve histology. RESULTS: Electrical stimulation and FK506 groups demonstrated improved functional recovery and myelinated axon counts distal to the repair compared with repair alone. Electrical stimulation provided improvements in nerve regeneration that were not different from optimized FK506 systemic administration. DISCUSSION: Providing ES after nerve repair improved regeneration and recovery in rats, with minimal differences in therapeutic efficacy to FK506, further demonstrating its clinical potential to improve management of nerve injuries.
Authors: Thomas M Brushart; Paul N Hoffman; Richard M Royall; Beth B Murinson; Christian Witzel; Tessa Gordon Journal: J Neurosci Date: 2002-08-01 Impact factor: 6.167
Authors: G M Hare; P J Evans; S E Mackinnon; T J Best; J R Bain; J P Szalai; D A Hunter Journal: Plast Reconstr Surg Date: 1992-02 Impact factor: 4.730
Authors: Roberta K Yang; James B Lowe; Julia B Sobol; Subhro K Sen; Daniel A Hunter; Susan E Mackinnon Journal: Plast Reconstr Surg Date: 2003-12 Impact factor: 4.730
Authors: Devyani Lal; Laura T Hetzler; Nijee Sharma; Robert D Wurster; Sam J Marzo; Kathryn J Jones; Eileen M Foecking Journal: Otolaryngol Head Neck Surg Date: 2008-07 Impact factor: 3.497
Authors: Tessa Gordon; K Ming Chan; Olawale A R Sulaiman; Esther Udina; Nasim Amirjani; Thomas M Brushart Journal: Neurosurgery Date: 2009-10 Impact factor: 4.654
Authors: Joseph Roh; Lauren Schellhardt; Grace C Keane; Daniel A Hunter; Amy M Moore; Alison K Snyder-Warwick; Susan E Mackinnon; Matthew D Wood Journal: Plast Reconstr Surg Date: 2022-04-01 Impact factor: 5.169
Authors: Grace C Keane; Deng Pan; Joseph Roh; Ellen L Larson; Lauren Schellhardt; Daniel A Hunter; Alison K Snyder-Warwick; Amy M Moore; Susan E Mackinnon; Matthew D Wood Journal: Hand (N Y) Date: 2020-07-15
Authors: Mohammed Barham; Michael Streppel; Orlando Guntinas-Lichius; Nicole Fulgham-Scott; Johannes Vogt; Wolfram F Neiss Journal: Front Neurosci Date: 2022-05-13 Impact factor: 5.152